- Home
- FHN vs TECH Comparison
FHN vs TECH Comparison
Compare FHN & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FHN
- TECH
- Stock Information
- Founded
- FHN 1864
- TECH 1976
- Country
- FHN United States
- TECH United States
- Employees
- FHN N/A
- TECH N/A
- Industry
- FHN Major Banks
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FHN Finance
- TECH Health Care
- Exchange
- FHN Nasdaq
- TECH Nasdaq
- Market Cap
- FHN 9.9B
- TECH 8.0B
- IPO Year
- FHN N/A
- TECH 1989
- Fundamental
- Price
- FHN $17.10
- TECH $48.10
- Analyst Decision
- FHN Buy
- TECH Buy
- Analyst Count
- FHN 16
- TECH 9
- Target Price
- FHN $21.78
- TECH $81.25
- AVG Volume (30 Days)
- FHN 6.9M
- TECH 2.2M
- Earning Date
- FHN 04-16-2025
- TECH 05-07-2025
- Dividend Yield
- FHN 3.47%
- TECH 0.63%
- EPS Growth
- FHN N/A
- TECH N/A
- EPS
- FHN 1.44
- TECH 0.98
- Revenue
- FHN $3,041,000,000.00
- TECH $1,196,016,000.00
- Revenue This Year
- FHN $12.07
- TECH $8.19
- Revenue Next Year
- FHN $4.58
- TECH $8.85
- P/E Ratio
- FHN $11.89
- TECH $49.09
- Revenue Growth
- FHN 3.37
- TECH 4.46
- 52 Week Low
- FHN $13.93
- TECH $46.44
- 52 Week High
- FHN $22.44
- TECH $85.57
- Technical
- Relative Strength Index (RSI)
- FHN 40.55
- TECH 33.97
- Support Level
- FHN $16.90
- TECH $46.44
- Resistance Level
- FHN $17.97
- TECH $53.00
- Average True Range (ATR)
- FHN 1.07
- TECH 3.30
- MACD
- FHN 0.01
- TECH -0.27
- Stochastic Oscillator
- FHN 42.73
- TECH 13.00
About FHN First Horizon Corporation
First Horizon Corp is the parent company of First Tennessee Bank, a prominent regional bank with about 200 branches around Tennessee. The company's reportable segments are: Commercial, Consumer & Wealth, Wholesale, and Corporate. The majority of its revenue is generated from Commercial, Consumer & Wealth. The Commercial, Consumer & Wealth segment offers financial products and services, including traditional lending and deposit taking, to commercial and consumer clients in the southern USA and other selected markets.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.